Reference / BPC-157
BPC-157
A synthetic peptide studied in laboratory and animal research on tissue repair.
Type: Synthetic pentadecapeptide (15 amino acids)
Origin: Sequence derived from a protein found in gastric juice
Status: Not approved by the FDA for human use
Evidence base: Mostly preclinical (cell and animal studies)
What the research covers
Published studies, largely in rodents, have examined BPC-157 in models of tendon, ligament, muscle, and gastrointestinal injury. These studies report effects on healing and on blood vessel growth in those models.
What the research does not show
Human clinical evidence is very limited. Findings from animal models do not establish safety or effectiveness in people, and the long-term effects are not well characterized. Much of the published work comes from a small number of research groups, so independent replication matters.
Regulatory and sport status
BPC-157 is not an FDA-approved drug. Regulators have raised safety questions about its use in compounded products, and it is prohibited in competitive sport under anti-doping rules. Rules change, so check current guidance from the FDA and your governing body.
Evaluating a supplier’s COA
- Lot number on the report matches the vial
- HPLC chromatogram shows one dominant peak, with purity stated
- Mass spectrometry confirms the expected molecular weight
- Testing done by an independent lab, with endotoxin screening if offered
Supplier
For laboratory research use only. This page is not medical advice and does not describe dosing or administration.